Venous Thromboembolism Prevention in Nephrotic Syndrome: The Role of Aspirin, Vitamin K Antagonists, and Direct Oral Anticoagulants

By afschroeder • June 10, 2025

Gholizadeh Ghozloujeh Z, Glassock RJ, Al Jurdi A, Jhaveri KD, Heidari-Bateni G, Bajpai D, Lerma E, Wu J, Abdipour A, Norouzi S. Venous Thromboembolism Prevention in Nephrotic Syndrome: The Role of Aspirin, Vitamin K Antagonists, and Direct Oral Anticoagulants. Kidney Int Rep. 2025 Feb 21;10(5):1335-1345. doi: 10.1016/j.ekir.2025.02.010. PMID: 40485694; PMCID: PMC12142514.

Tags: Anticoagulation, Aspirin, Emeritus, Harbor UCLA, hypercoagulability, Nephrology, nephrotic syndrome, Publications, venous thromboembolic events

Non-canonical IL-22 receptor signaling remodels the oral mucosal barrier during Candida albicans immunosurveillance

Millet N, Sekar J, Solis NV, Miao J, Millet A, Aggor FEY, Wildeman A, Cook ME, Davari A, Peters BM, Lionakis MS, Gaffen SL, Jendzjowsky[...]

Discharge criteria from nephrology follow-up back to primary care in modern-era CKD: a review of main guidelines

Oliva-Damaso N, Martinez-Palma L, Oliva-Damaso E, Payan J, Glassock RJ. Discharge criteria from nephrology follow-up back to primary care in modern-era CKD: a review of[...]

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Baricitinib vs. Tocilizumab

Nadig N, Bhimraj A, Cawcutt K, Chiotos K, Dzierba AL, Kim AY, Martin GS, Pearson JC, Shumaker AH, Baden LR, Bedimo R, Cheng VC, Chew[...]